● Recruiting

A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)

Condition: Hepatocellular Carcinoma (HCC) · Sponsor: Bristol-Myers Squibb

PhasePhase 1/Phase 2

Planned participants198

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

The purpose of this study is to evaluate the safety and tolerability of Pumitamig alone or in combination with Ipilimumab in participants with first-line advanced or unresectable Hepatocellular Carcinoma (HCC)

This description comes directly from the study's public registry record.

Talk to the study team

BMS Clinical Trials Contact Center www.BMSClinicalTrials.com · 855-907-3286 · Clinical.Trials@bms.com

First line of the email MUST contain NCT # and Site #.

Always discuss trial participation with your own doctor first.

Locations (64)

Local Institution - 0137	Duarte, California, United States	Not Yet Recruiting
Local Institution - 0070	Los Angeles, California, United States	Not Yet Recruiting
Local Institution - 0107	Chicago, Illinois, United States	Not Yet Recruiting
Local Institution - 0134	Detroit, Michigan, United States	Not Yet Recruiting
John Theurer Cancer Center at Hackensack University Medical Center	Hackensack, New Jersey, United States	Recruiting
Local Institution - 0100	Mineola, New York, United States	Not Yet Recruiting
Providence Portland Medical Center	Portland, Oregon, United States	Recruiting
Providence St. Vincent Medical Center	Portland, Oregon, United States	Recruiting
Tennessee Oncology	Nashville, Tennessee, United States	Recruiting
Vanderbilt University Medical Center	Nashville, Tennessee, United States	Recruiting
Local Institution - 0083	Seattle, Washington, United States	Not Yet Recruiting
Royal Prince Alfred Hospital	Camperdown, New South Wales, Australia	Recruiting

+ 52 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07291076